Patent: 6,090,777
✉ Email this page to a colleague
Summary for Patent: 6,090,777
| Title: | Method to reduce myocardial injury during acute myocardial infarction |
| Abstract: | A therapeutic or prophylactic treatment method of acute myocardial infarction, comprising administering exogenous C1-esterase inhibitor, alone or in combination with other drugs, to a patient with acute myocardial infarction or to a patient at risk for acute myocardial infarction. The treatment inhibits the inflammatory reaction, more specifically the activation of the complement system, which occurs in the course of acute myocardial infarction. The C1-esterase inhibitor may include C1-esterase inhibitor purified from plasma or other biological materials, or recombinant C1-esterase inhibitor, or recombinant variants derived therefrom, or recombinant constructs of other inhibitors having a specificity similar to C1-esterase inhibitor. |
| Inventor(s): | Hack; Cornelis Erik (Diemen, NL), Hermens; Willem Theodoor (Gronsveld, NL) |
| Assignee: | Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL) |
| Application Number: | 08/604,933 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,090,777
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2013-09-01 |
| Pharming Americas Bv | RUCONEST | c1 esterase inhibitor (recombinant) | For Injection | 125495 | 07/16/2014 | ⤷ Try a Trial | 2013-09-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
